ImmunoPrecise Antibodies Ltd. (HYFT) Ownership
HYFT ownership summary
as of October 18, 2026- Institutions
- 9.3% of shares outstanding
- Insiders
- 9.16% of shares outstanding
- Shares outstanding
- 47.1M
- Float
- 42.7M shares available to trade
- Short interest
- 1.52% 707K shares short
- Days to cover
- 3.59 short interest down 3.1% vs prior month
- Institutions 9.29%
- Insiders 9.16%
- Other investors 81.54%
HYFT top institutional holders
20 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Ingalls & Snyder LLC | 6.44% | 3.0M | $4.0M | +128,439 (+4.4%) | June 30, 2026 |
| 2 | Susquehanna International Group, LLP | 1.11% | 521K | $682,207 | −13,247 (−2.5%) | June 30, 2026 |
| 3 | Renaissance Technologies Corp | 0.45% | 213K | $279,528 | −19,100 (−8.2%) | June 30, 2026 |
| 4 | BlackRock Inc | 0.33% | 154K | $202,278 | +154,411 (0.0%) | June 30, 2026 |
| 5 | Marshall Wace Asset Management Ltd | 0.29% | 136K | $178,117 | +110,721 (+438.6%) | June 30, 2026 |
| 6 | Bank of Montreal | 0.17% | 78K | $102,111 | +8,000 (+11.4%) | June 30, 2026 |
| 7 | BMO Capital Markets Corp. | 0.17% | 78K | $102,111 | +8,000 (+11.4%) | June 30, 2026 |
| 8 | Allianz Asset Management AG | 0.07% | 35K | $45,850 | — | June 30, 2026 |
| 9 | GSA Capital Partners LLP | 0.07% | 35K | $45,228 | +34,525 (0.0%) | June 30, 2026 |
| 10 | Gradient Capital Advisors, LLC | 0.06% | 27K | $34,782 | — | June 30, 2026 |
| 11 | Geode Capital Management, LLC | 0.05% | 25K | $33,392 | +9,356 (+58.0%) | June 30, 2026 |
| 12 | Federation des caisses Desjardins du Quebec | 0.05% | 23K | $30,477 | — | June 30, 2026 |
| 13 | Tradition Wealth Management LLC | 0.03% | 13K | $17,262 | — | June 30, 2026 |
| 14 | XTX Topco Ltd | 0.03% | 12K | $16,072 | −160,278 (−92.9%) | June 30, 2026 |
| 15 | Virtu Financial LLC | 0.02% | 11K | $14,506 | −37,855 (−77.4%) | June 30, 2026 |
| 16 | Morgan Stanley - Brokerage Accounts | 0.02% | 11K | $14,043 | — | June 30, 2026 |
| 17 | Mariner Wealth Advisors LLC | 0.02% | 10K | $13,100 | — | June 30, 2026 |
| 18 | UBS Group AG | 0.02% | 9,767 | $12,795 | −32,564 (−76.9%) | June 30, 2026 |
| 19 | Group One Trading, LLC | 0.01% | 4,749 | $6,221 | −5,603 (−54.1%) | June 30, 2026 |
| 20 | Hanson Mcclain Inc | 0.01% | 2,850 | $3,734 | — | June 30, 2026 |
Value at the latest close. Change = shares bought or sold in the latest quarterly filing (13F). In the top 20, 7 holders added 453K shares and 6 cut 269K.
HYFT top mutual fund and ETF holders
3 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | iShares Micro-Cap ETF | 0.29% | 138K | $180,851 | −952 (−0.7%) | September 30, 2026 |
| 2 | 1290 VT Micro Cap K | 0.02% | 9,593 | $12,567 | — | August 31, 2026 |
| 3 | Fidelity Nasdaq Composite Index | 0.02% | 9,356 | $12,256 | −16,134 (−63.3%) | August 31, 2026 |
Funds report holdings monthly or quarterly; dates differ by fund.
HYFT shares outstanding
Year-end shares outstanding, adjusted for splits.
Who owns HYFT
Institutional investors own 9.3% of ImmunoPrecise Antibodies's shares and insiders 9.16%. The largest holder is Ingalls & Snyder LLC with 6.44% of the shares (3.0M), as of June 30, 2026. Among the top 20 institutions, 7 added shares and 6 reduced their stake in the latest filings. Short interest is 1.52% of the float, or 3.59 days of average trading volume. The share count rose 8,290.6% since 2014.
Related: HYFT analyst forecast, HYFT key metrics. See the HYFT stock overview for the latest quote and news.
HYFT ownership FAQ
Who owns the most ImmunoPrecise Antibodies stock?
The largest shareholders of ImmunoPrecise Antibodies are Ingalls & Snyder LLC (6.44%), Susquehanna International Group, LLP (1.11%), Renaissance Technologies Corp (0.45%), BlackRock Inc (0.33%), Marshall Wace Asset Management Ltd (0.29%).
What percentage of ImmunoPrecise Antibodies is owned by institutions?
Institutions hold 9.3% of ImmunoPrecise Antibodies's shares outstanding; insiders hold 9.16%.
Which funds own ImmunoPrecise Antibodies?
The largest fund holders of ImmunoPrecise Antibodies are iShares Micro-Cap ETF (0.29%), 1290 VT Micro Cap K (0.02%), Fidelity Nasdaq Composite Index (0.02%).
What is ImmunoPrecise Antibodies's short interest?
707K shares of ImmunoPrecise Antibodies were sold short, 1.52% of the float; at the average daily volume it would take 3.59 days to cover.
How many shares of ImmunoPrecise Antibodies are outstanding?
ImmunoPrecise Antibodies has 47.1M shares outstanding, of which 42.7M are in the public float.